1. Berrigan MJ, Marinello AJ, Pavelic Z, Williams CJ, Struck RF, Gurtoo HL (1982) Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism. Cancer Res 42: 3688?3695
2. Brock N (1980) The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics. In: G Mathei, FM Muggia (ededs), Cancer Chemo- and Immunopharmacology, p 274, Berlin, Springer-Verlag
3. Brock N, Stekar J, Pohl J, Niemeyer U, Scheffler G (1979) Acrolein, the causative factor of urotoxic side effects of cyclophosphamide, ifosfamide, trofosfamide and sulfosfamide. Drug Res 29: 659?661
4. Cox PJ (1979) Cyclophosphamide cystitis ? Identification of acrolein as the causative agent. Biochem Pharmacol 28: 2045?2049
5. Cox PJ, Phillips BJ, Thomas P (1975) The enzymatic basis of the selective action of cyclophosphamide. Cancer Res 35: 3755?3761